Less Genome, More Gain: Genome Reduction Enhances Transaminase-Producing E. coli in a Scale-Down Bioreactor.

IF 3 4区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Engineering in Life Sciences Pub Date : 2026-04-27 eCollection Date: 2026-04-01 DOI:10.1002/elsc.70080
Gennaro Avolio, Simon Klaffl, Ralf Takors
{"title":"Less Genome, More Gain: Genome Reduction Enhances Transaminase-Producing <i>E. coli</i> in a Scale-Down Bioreactor.","authors":"Gennaro Avolio, Simon Klaffl, Ralf Takors","doi":"10.1002/elsc.70080","DOIUrl":null,"url":null,"abstract":"<p><p>In large-scale bioprocesses, mixing limitations and design constraints cause the onset of heterogeneous environments, subjecting the cells to continuously changing external conditions, often reducing their performance compared to laboratory conditions. This study evaluated the performance in producing a heterologous transaminase (TA) of a genome-reduced <i>Escherichia coli</i> strain (RM214) in a STR-PFR scale-down system, benchmarking it against a wild-type strain. Under cycles of glycerol limitation and starvation, combined with oxygen limitation in later process stages, RM214 outperformed the wild-type strain. Due to its lower maintenance coefficient, RM214 showed a remarkable biomass increase of +53% and a boosted final volumetric activity with a +65% increase. These results were achieved with significantly reduced biomass-specific substrate uptake rates and respiratory parameters, both crucial for optimizing large-scale processes. This study underscores the applicability and enhanced robustness of genome-reduced strains in heterogeneous large-scale environments.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"26 ","pages":"e70080"},"PeriodicalIF":3.0000,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13112000/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Engineering in Life Sciences","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/elsc.70080","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In large-scale bioprocesses, mixing limitations and design constraints cause the onset of heterogeneous environments, subjecting the cells to continuously changing external conditions, often reducing their performance compared to laboratory conditions. This study evaluated the performance in producing a heterologous transaminase (TA) of a genome-reduced Escherichia coli strain (RM214) in a STR-PFR scale-down system, benchmarking it against a wild-type strain. Under cycles of glycerol limitation and starvation, combined with oxygen limitation in later process stages, RM214 outperformed the wild-type strain. Due to its lower maintenance coefficient, RM214 showed a remarkable biomass increase of +53% and a boosted final volumetric activity with a +65% increase. These results were achieved with significantly reduced biomass-specific substrate uptake rates and respiratory parameters, both crucial for optimizing large-scale processes. This study underscores the applicability and enhanced robustness of genome-reduced strains in heterogeneous large-scale environments.

更少的基因组,更多的收益:基因组减少提高转氨酶生产大肠杆菌在缩小规模的生物反应器。
在大规模生物过程中,混合限制和设计限制导致异质性环境的发生,使细胞受到不断变化的外部条件的影响,与实验室条件相比,通常会降低其性能。本研究在STR-PFR缩小系统中评估了基因组减少的大肠杆菌菌株(RM214)产生异源转氨酶(TA)的性能,并将其与野生型菌株进行了比较。在甘油限制和饥饿循环下,再加上后期的氧气限制,RM214的表现优于野生型菌株。由于维持系数较低,RM214的生物量显著增加了53%,最终体积活性提高了65%。这些结果是在显著降低生物量特异性底物吸收率和呼吸参数的情况下实现的,这两者对于优化大规模过程都至关重要。这项研究强调了基因组减少菌株在异质大规模环境中的适用性和增强的稳健性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Engineering in Life Sciences
Engineering in Life Sciences 工程技术-生物工程与应用微生物
CiteScore
6.40
自引率
3.70%
发文量
81
审稿时长
3 months
期刊介绍: Engineering in Life Sciences (ELS) focuses on engineering principles and innovations in life sciences and biotechnology. Life sciences and biotechnology covered in ELS encompass the use of biomolecules (e.g. proteins/enzymes), cells (microbial, plant and mammalian origins) and biomaterials for biosynthesis, biotransformation, cell-based treatment and bio-based solutions in industrial and pharmaceutical biotechnologies as well as in biomedicine. ELS especially aims to promote interdisciplinary collaborations among biologists, biotechnologists and engineers for quantitative understanding and holistic engineering (design-built-test) of biological parts and processes in the different application areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书